To validate our scRNA‐seq findings, mice inoculated with tumor cells from a Kras‐driven lung tumor (LKR13 cell line) were treated with the miR-138-5p/miR-200c combination, and TILs were analyzed one week later by flow cytometry for expression of specific cell surface markers. The gene discussed is KRAS; the disease is neoplasm.